Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

Advancements in photobiomodulation for generating functional beta cells from adipose derived stem cells in 3D culture: a comprehensive review.

Daramola O., Abrahamse H., Crous A.

Narrative Review on Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Stem Cell Res Ther (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41013564
PMCID
PMC12465650
DOI
10.1186/s13287-025-04643-5
Citations
1

Abstract (original English)

The differentiation of stem cells into functional insulin-producing beta (β) cells is a promising strategy in regenerative medicine, particularly in addressing the increasing prevalence of diabetes mellitus. Among the various strategies investigated for guiding stem cell differentiation, photobiomodulation (PBM) has emerged as an innovative approach to enhance the differentiation efficiency of adipose-derived stem cells (ADSCs) into functional insulin-producing β cells. Photobiomodulation involves the use of specific wavelengths of light to regulate cellular activity, offering advantages such as non-invasive modulation of signalling pathways and potential improvements in differentiation efficiency. This review focuses on how PBM can facilitate the differentiation of ADSCs into functional insulin-producing β cells. While other factors such as growth factors, extracellular matrix (ECM) interactions, and genetic modifications also play a role in β-cell development, they are only discussed in relation to their impact on PBM processes. By refining the scope, this review aims to provide the utility of PBM technique in differentiation of ADSCs into functional insulin-producing β cells within three-dimensional (3D) cell culture systems and its potential clinical applications. We delve into the mechanisms of β cell differentiation, highlighting the pivotal role of key signalling pathway

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansInsulin-Secreting CellsCell DifferentiationAdipose TissueStem CellsAnimalsCell Culture Techniques, Three DimensionalLow-Level Light Therapy

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research